Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
During treatment with pirtobrutinib, some side effects may occur, and these effe···【more】
Release date：2026-03-25Recommended：121
For Patients with Severe Renal Impairment(1). If the current dose is 200 mg once···【more】
Release date：2026-03-25Recommended：141
Pirtobrutinib is a non-covalent (reversible) Bruton's tyrosine kinase (BTK) ···【more】
Release date：2026-03-25Recommended：119
Enasidenib helps restore the normal differentiation of leukemia cells by inhibit···【more】
Release date：2026-03-24Recommended：70
The dosage and administration of enasidenib must strictly follow medical advice ···【more】
Release date：2026-03-24Recommended：84
The use of tepotinib must strictly adhere to the principle of individualized tre···【more】
Release date：2026-03-24Recommended：93
Side Effects of TepotinibPatients should schedule regular follow-ups during trea···【more】
Release date：2026-03-24Recommended：94
On May 28, 2021, Amgen announced that the U.S. Food and Drug Administration (FDA···【more】
Release date：2026-03-23Recommended：84
On January 17, 2025, Amgen announced that the U.S. Food and Drug Administration ···【more】
Release date：2026-03-23Recommended：98
KRAS mutations have long been considered a major challenge in cancer research, r···【more】
Release date：2026-03-23Recommended：84
Sotorasib is a KRASG12C inhibitor developed by Amgen. It received accelerated ap···【more】
Release date：2026-03-23Recommended：75
Cabozantinib (Cabometyx) was first approved by the FDA in 2012. It is a non‑spec···【more】
Release date：2026-03-20Recommended：84
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
